Axonics Inc (AXNX)
67.58
-0.09
(-0.13%)
USD |
NASDAQ |
May 17, 16:00
67.58
0.00 (0.00%)
After-Hours: 20:00
Axonics Research and Development Expense (TTM): 37.89M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 37.89M |
| December 31, 2023 | 34.89M |
| September 30, 2023 | 33.28M |
| June 30, 2023 | 33.04M |
| March 31, 2023 | 31.23M |
| December 31, 2022 | 34.41M |
| September 30, 2022 | 36.49M |
| June 30, 2022 | 37.20M |
| March 31, 2022 | 39.16M |
| December 31, 2021 | 37.30M |
| September 30, 2021 | 35.23M |
| June 30, 2021 | 34.30M |
| Date | Value |
|---|---|
| March 31, 2021 | 31.57M |
| December 31, 2020 | 29.06M |
| September 30, 2020 | 27.06M |
| June 30, 2020 | 24.20M |
| March 31, 2020 | 22.70M |
| December 31, 2019 | 20.07M |
| September 30, 2019 | 18.73M |
| June 30, 2019 | 17.77M |
| March 31, 2019 | 19.08M |
| December 31, 2018 | 19.40M |
| September 30, 2018 | 17.99M |
| June 30, 2018 | 17.23M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.77M
Minimum
Jun 2019
39.16M
Maximum
Mar 2022
30.78M
Average
33.16M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.444B |
| Cutera Inc | 19.94M |
| Stereotaxis Inc | 9.77M |
| Electromed Inc | 0.778M |
| Myomo Inc | 3.116M |